Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to James Veblen DeGregori

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

DeGregori, James

One or more keywords matched the following items that are connected to DeGregori, James

Item Type	Name
Academic Article	Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia.
Academic Article	ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53.
Academic Article	Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibition.
Academic Article	A receptor tyrosine kinase network composed of fibroblast growth factor receptors, epidermal growth factor receptor, v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, and hepatocyte growth factor receptor drives growth and survival of head and neck squamous carcinoma cell lines.
Academic Article	Rational combination of a MEK inhibitor, selumetinib, and the Wnt/calcium pathway modulator, cyclosporin A, in preclinical models of colorectal cancer.
Academic Article	Contrasting roles for C/EBPa and Notch in irradiation-induced multipotent hematopoietic progenitor cell defects.
Academic Article	Aging-associated inflammation promotes selection for adaptive oncogenic events in B cell progenitors.
Academic Article	ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia.
Academic Article	AZ1366: An Inhibitor of Tankyrase and the Canonical Wnt Pathway that Limits the Persistence of Non-Small Cell Lung Cancer Cells Following EGFR Inhibition.
Academic Article	Coupling an EML4-ALK-centric interactome with RNA interference identifies sensitizers to ALK inhibitors.
Grant	Rationally designed targeted therapeutic approaches for NSCLC
Academic Article	ALK is a critical regulator of the MYC-signaling axis in ALK positive lung cancer.
Academic Article	Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion.

Search Criteria

Triacetoneamine N Oxyl